[Skip to Content]
[Skip to Content Landing]
Article
May 1993

Sphincter-Saving Alternatives in the Management of Adenocarcinoma Involving the Distal Rectum5-Year Follow-up Results in 40 Patients

Author Affiliations

From the Department of Colon and Rectal Surgery, Lahey Clinic Medical Center, Burlington, Mass. Dr Stahl is now affiliated with the Department of Surgery, Georgetown University Medical Center, Washington, DC.

Arch Surg. 1993;128(5):545-550. doi:10.1001/archsurg.1993.01420170079011
Abstract

• We reviewed the treatment outcome in 40 patients undergoing full-thickness local excision (seven patients) or electrocoagulation (33 patients) for adenocarcinoma of the rectum. Patients were followed up for a minimum of 5 years or until death (mean follow-up, 7.6 years). Twenty-two patients (55%) survived 5 years free of disease or were free of disease at the time of death due to other causes following local treatment. Eight (62%) of 13 patients with persistent or locally recurrent disease were successfully treated with additional local therapy, rectal resection, or combined radiation therapy and chemotherapy. Overall, 30(75%) of 40 patients embarking on a program of local treatment for carcinoma of the rectum survived 5 years free of disease or were free of disease at the time of death due to other causes.

(Arch Surg. 1993;128:545-550)

×